RYTIZER

Serial Number 86692275
606

Registration Progress

Application Filed
Jul 14, 2015
Under Examination
Jan 19, 2016
Approved for Publication
Nov 24, 2015
Published for Opposition
Nov 24, 2015
Registered

Trademark Image

RYTIZER

Basic Information

Serial Number
86692275
Filing Date
July 14, 2015
Published for Opposition
November 24, 2015
Abandonment Date
February 25, 2019
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Feb 25, 2019
Classes
005

Rights Holder

Pfizer Inc.

03
Address
235 East 42nd Street
New York, NY 10017

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Pfizer Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Katrina Edge

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

31 events
Date Code Type Description Documents
Feb 25, 2019 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 25, 2019 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jun 12, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 11, 2018 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 11, 2018 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jun 7, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 7, 2018 EXT5 S SOU EXTENSION 5 FILED Loading...
Jan 4, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 2, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 2, 2018 EXT4 S SOU EXTENSION 4 FILED Loading...
Jan 2, 2018 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jun 30, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 28, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 28, 2017 EXT3 S SOU EXTENSION 3 FILED Loading...
Jun 28, 2017 EX3G S SOU EXTENSION 3 GRANTED Loading...
Dec 17, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 15, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 15, 2016 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 15, 2016 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 2, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 30, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 30, 2016 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 30, 2016 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 19, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 24, 2015 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 24, 2015 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 4, 2015 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 15, 2015 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 15, 2015 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 17, 2015 NWAP I NEW APPLICATION ENTERED Loading...
Jul 17, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005